These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
685 related articles for article (PubMed ID: 20487503)
41. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Thomas DR Clin Nutr; 2007 Aug; 26(4):389-99. PubMed ID: 17499396 [TBL] [Abstract][Full Text] [Related]
42. Sarcopenia and decreased muscle strength in the elderly woman: resistance training as a safe and effective intervention. Foster-Burns SB J Women Aging; 1999; 11(4):75-85. PubMed ID: 10721690 [TBL] [Abstract][Full Text] [Related]
43. Research hypotheses on muscle wasting, aging, loss of function and disability. Pahor M; Kritchevsky S J Nutr Health Aging; 1998; 2(2):97-100. PubMed ID: 10993575 [TBL] [Abstract][Full Text] [Related]
44. Effect of strength training on muscle function in elderly hospitalized patients. Suetta C; Magnusson SP; Beyer N; Kjaer M Scand J Med Sci Sports; 2007 Oct; 17(5):464-72. PubMed ID: 17924926 [TBL] [Abstract][Full Text] [Related]
45. Sarcopenia--exercise as a treatment strategy. Taaffe DR Aust Fam Physician; 2006 Mar; 35(3):130-4. PubMed ID: 16525526 [TBL] [Abstract][Full Text] [Related]
46. The role of systemic inflammation in age-related muscle weakness and wasting. Degens H Scand J Med Sci Sports; 2010 Feb; 20(1):28-38. PubMed ID: 19804579 [TBL] [Abstract][Full Text] [Related]
47. Mitochondrial theory of aging in human age-related sarcopenia. Parise G; De Lisio M Interdiscip Top Gerontol; 2010; 37():142-56. PubMed ID: 20703060 [TBL] [Abstract][Full Text] [Related]
48. mTOR signaling as a target of amino acid treatment of the age-related sarcopenia. D'Antona G; Nisoli E Interdiscip Top Gerontol; 2010; 37():115-41. PubMed ID: 20703059 [TBL] [Abstract][Full Text] [Related]
49. Sarcopenic obesity: satellite cells in the aging muscle. Thornell LE Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):22-7. PubMed ID: 21088571 [TBL] [Abstract][Full Text] [Related]
50. Sarcopenia: current theories and the potential beneficial effect of creatine application strategies. Candow DG Biogerontology; 2011 Aug; 12(4):273-81. PubMed ID: 21373890 [TBL] [Abstract][Full Text] [Related]
51. Muscle apoptotic response to denervation, disuse, and aging. Siu PM Med Sci Sports Exerc; 2009 Oct; 41(10):1876-86. PubMed ID: 19727026 [TBL] [Abstract][Full Text] [Related]
52. Skeletal muscle: increasing the size of the locomotor cell. Karagounis LG; Hawley JA Int J Biochem Cell Biol; 2010 Sep; 42(9):1376-9. PubMed ID: 20541033 [TBL] [Abstract][Full Text] [Related]
53. Neuromuscular Changes with Aging and Sarcopenia. Clark BC J Frailty Aging; 2019; 8(1):7-9. PubMed ID: 30734824 [TBL] [Abstract][Full Text] [Related]
54. Muscle weakness and neuromuscular junctions in aging and disease. Shigemoto K; Kubo S; Mori S; Yamada S; Akiyoshi T; Miyazaki T Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S137-47. PubMed ID: 20590829 [TBL] [Abstract][Full Text] [Related]
55. Motor unit number estimation and neuromuscular fidelity in 3 stages of sarcopenia. Gilmore KJ; Morat T; Doherty TJ; Rice CL Muscle Nerve; 2017 May; 55(5):676-684. PubMed ID: 27576772 [TBL] [Abstract][Full Text] [Related]